Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

Peer Review reports

Original Submission
2 Jun 2003	Submitted	Original manuscript
11 Jun 2003	Reviewed	Reviewer Report - Antonio Craxì
24 Jun 2003	Reviewed	Reviewer Report - Kim Krogsgaard
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
29 Aug 2003	Editorially accepted
29 Aug 2003	Article published	10.1186/1471-230X-3-24

Back to article page